In March 2013, Pfizer shares broke through resistance at $26.50, which subsequently became support for the price. Since then, the stock has tested this level 6 times, but has never been able to break through it. On December 13, 2023, quotes again dropped to support at 26.50 USD and judging by the sharply increased trading volumes, investors began to show interest in the company’s securities. In this situation, we should expect a rebound from the level with a subsequent rise in price to the nearest resistance at 33.00 USD.
免责声明
这些信息和出版物并非旨在提供，也不构成TradingView提供或认可的任何形式的财务、投资、交易或其他类型的建议或推荐。请阅读使用条款了解更多信息。